News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,853 Results
Type
Article (1182)
Company Profile (3)
Press Release (37668)
Section
Business (14096)
Career Advice (13)
Deals (2938)
Drug Delivery (2)
Drug Development (3248)
Employer Resources (3)
FDA (571)
Job Trends (640)
News (18495)
Policy (1529)
Tag
2027 Pharm Country Standard (1)
Academia (62)
Accelerated approval (2)
Adcomms (1)
Allergies (1)
Alliances (2637)
ALS (10)
Alzheimer's disease (114)
Antibody-drug conjugate (ADC) (14)
Approvals (597)
Artificial intelligence (50)
ASCO (9)
Autoimmune disease (14)
Automation (1)
Bankruptcy (21)
Belgium (10)
Best Places to Work (378)
BIO (6)
Biologics (1)
Biosimilars (4)
BioSpace Insights (1)
Biotechnology (16)
Bispecific (1)
Bladder cancer (9)
Brain cancer (4)
Breast cancer (77)
Cancer (299)
Cardiovascular disease (10)
Career advice (13)
CAR-T (1)
CDC (1)
Cell therapy (26)
Clinical research (2780)
Collaboration (112)
Commercialization (1)
Compensation (11)
Complete response letters (1)
COVID-19 (231)
CRISPR (1)
C-suite (80)
Cystic fibrosis (3)
Data (305)
Depression (8)
Dermatology (1)
Diabetes (11)
Diagnostics (463)
Digital health (4)
Diversity, equity & inclusion (2)
Drug discovery (29)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (4651)
Employer resources (3)
ESMO (14)
Events (5090)
Executive appointments (75)
FDA (714)
Fragile X (3)
Funding (112)
Gene editing (3)
Generative AI (1)
Gene therapy (3)
GLP-1 (29)
Government (123)
Guidances (13)
Healthcare (1004)
Hematology (1)
HIV (1)
Huntington's disease (3)
IgA nephropathy (2)
Immunology and inflammation (2)
Immuno-oncology (3)
Indications (4)
Infectious disease (244)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (9)
Interviews (3)
IPO (1173)
Job creations (270)
Job search strategy (10)
Kidney disease (4)
Layoffs (13)
Legal (606)
Liver cancer (1)
Longevity (2)
Lung cancer (22)
Lymphoma (3)
Machine learning (5)
Management (1)
Manufacturing (41)
MASH (5)
Medical device (764)
Medtech (776)
Mergers & acquisitions (1886)
Metabolic disorders (22)
mRNA (5)
Multiple sclerosis (4)
Netherlands (1)
Neurodegenerative disease (15)
Neuropsychiatric disorders (2)
Neuroscience (167)
NextGen: Class of 2026 (271)
Non-profit (97)
Obesity (5)
Opinion (2)
Ovarian cancer (3)
Pain (15)
Pancreatic cancer (25)
Parkinson's disease (9)
Partnered (12)
Patents (30)
Patient recruitment (24)
Patient selection (4)
People (4310)
Pharmaceutical (4)
Phase 1 (845)
Phase 2 (1402)
Phase 3 (836)
Pipeline (390)
Postmarket research (65)
Preclinical (369)
Press Release (2)
Prostate cancer (21)
Psychedelics (4)
Radiopharmaceuticals (29)
Rare diseases (49)
Real estate (279)
Recruiting (1)
Regulatory (1009)
Reports (23)
Research institute (72)
Rett syndrome (5)
RNA editing (3)
RSV (2)
Schizophrenia (5)
Series A (8)
Series B (4)
Service/supplier (2)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (201)
State (1)
Supply chain (3)
Vaccines (34)
Venture capital (1)
Weight loss (2)
Women's health (3)
Date
Today (6)
Last 7 days (33)
Last 30 days (129)
Last 365 days (1596)
2026 (1294)
2025 (1683)
2024 (1945)
2023 (2204)
2022 (2965)
2021 (3686)
2020 (2885)
2019 (1971)
2018 (1529)
2017 (1445)
2016 (1386)
2015 (1707)
2014 (1423)
2013 (1177)
2012 (1323)
2011 (1320)
2010 (1433)
Location
Africa (38)
Alabama (2)
Arizona (14)
Asia (1428)
Australia (132)
California (391)
Canada (1281)
China (10)
Colorado (18)
Connecticut (7)
Delaware (12)
Europe (2985)
Florida (102)
Georgia (10)
Idaho (3)
Illinois (43)
India (6)
Indiana (57)
Japan (30)
Kansas (3)
Kentucky (2)
Louisiana (3)
Maryland (31)
Massachusetts (291)
Michigan (56)
Minnesota (81)
Montana (9)
Nebraska (3)
Nevada (10)
New Hampshire (11)
New Jersey (288)
New Mexico (7)
New York (234)
North Carolina (82)
North Dakota (1)
Northern California (195)
Ohio (20)
Oklahoma (4)
Oregon (1)
Pennsylvania (216)
Puerto Rico (1)
South America (51)
South Carolina (1)
Southern California (121)
Tennessee (10)
Texas (224)
United States (2245)
Utah (6)
Virginia (10)
Washington D.C. (1)
Washington State (22)
Wisconsin (45)
Wyoming (3)
38,853 Results for "genfit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
September 28, 2026
·
24 min read
Press Releases
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
September 14, 2026
·
7 min read
Press Releases
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
September 9, 2026
·
12 min read
Press Releases
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
September 11, 2026
·
5 min read
Press Releases
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
·
4 min read
Press Releases
GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026
September 3, 2026
·
8 min read
Press Releases
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
June 15, 2026
·
4 min read
Press Releases
GENFIT: NASHnext®, Powered by GENFIT’s Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
June 9, 2026
·
9 min read
Press Releases
GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
May 26, 2026
·
10 min read
Press Releases
GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)
April 20, 2026
·
8 min read
1 of 3,886
Next
